Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation

Blood

Volumn 103, Issue 11, 2004, Pages 4259-4267

  Shafarenko, Marianna ^a   Amanullah, Arshad ^a   Gregory, Bernard ^a   Liebermann, Dan A ^a   Hoffman, Barbara ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CYTOCHROME C; ESTRADIOL; INTERLEUKIN 6; MYC PROTEIN; PROTEIN FOS; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL DEATH; CELL DIFFERENTIATION; CELL STIMULATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; FLOW CYTOMETRY; GENE FUNCTION; GENE MUTATION; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; MYELOBLAST; MYELOID LEUKEMIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM;

EID: 2542432106     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2704     Document Type: Article

References (27)

1. Liebermann DA, Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene. 2002;21:3391-3402.
2. Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene. 2002;21:3414-3421.
3. Liebermann DA, Gregory B, Hoffman B. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int J Oncol. 1998;12:685-700.
4. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol. 1993;13:841-851.
5. Hoffman B, Liebermann DA. c-Myc and apoptosis. Oncogene. 1998;17:3351-3357.
6. Hoffman-Liebermann B, Liebermann DA. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol Cell Biol. 1991;11;2375-2381.
7. Amanullah A, Liebermann DA, Hoffman B. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation. Oncogene. 2000;19:2967-2977.
8. Liebermann DA, Hoffman-Liebermann B. Protooncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene. 1989;4:583-592.
9. Wigler M, Pellicer A, Silverstein S, Axel R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell. 1978;14:725-731.
10. Selvakumaran M, Liebermann DA, Hoffman-Liebermann B. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol Cell Biol. 1992;12;2493-2500.
11. Hawley RG. High-titer retroviral vectors for efficient transduction of functional genes into murine hematopoietic stem cells. Ann N Y Acad Sci. 1994;716:327-330.
12. Reichmann E, Schwarz H, Deiner EM, et al. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell. 1992;71:1103-1116.
13. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Dissection of the immediate early response of myeloid leukemia cells to terminal differentiation and growth inhibitory stimuli. Cell Growth Differ. 1990;1:637-645.
14. Krishnaraju K, Nguyen HQ, Liebermann DA, Hoffman B. The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol Cell Biol. 1995;15:5499-5507.
15. Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17:3237-3245.
16. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;28:1309-1312.
17. Reed JC. Bcl-2 family proteins. Oncogene. 1998;17:3225-3236.
18. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899-1911.
19. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;28:1305-1308.
20. Amanullah A, Liebermann DA, Hoffman B. Deregulated c-Myc prematurely recruits both type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation. Oncogene. 2002;21:1600-1610.
21. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20:2390-2400.
22. Jacobs-Helber SM, Wickrema A, Birrer MJ, Sawyer ST. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol Cell Biol. 1998;1:3699-3707.
23. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene. 2001;20:2401-2412.
24. Sawyers CL, Denny CT, Witte ON. Leukemia and the disruption of normal hematopoiesis. Cell. 1991;64:337-350.
25. Meinhardt G, Eppinger E, Schmidmaier R. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells. Anti-cancer Drugs. 2002;7:725-733.
26. Volm M, Sauerbrey A, Zintl F, Koomagi R, Efferth T. Protein expression profile of newly diagnosed acute lymphoblastic leukemia in children developing relapses. Oncol Rep. 2002;9:965-969.
27. Eibl B, Greiter E, Grunewald K, et al. Expression of c-fos correlates with IFN-alpha responsiveness in Philadelphia chromosome positive chronic myelogenous leukemia. Cytokines Mol Therapy. 1995;1:29-38.